Literature DB >> 23543063

IL-6 polymorphisms: a useful genetic tool for inflammation research?

Patricia Woo1, Steve E Humphries.   

Abstract

In 1998, we described a novel polymorphism in the promoter (G>C, rs1800795) of the IL-6 (IL6) gene. The common allele, G, exhibited higher transcriptional activity in gene reporter assays and was associated with higher serum IL-6 levels in a small cohort of healthy subjects. We explored the ethnic distribution of these alleles and found significant differences among people of mixed European descent, Africans, and Gujarati Asians. Disease association was established in a cohort of 92 children of mixed European descent from the United Kingdom with systemic juvenile idiopathic arthritis (sJIA), with the GG genotype being significantly increased in sJIA cases compared with that in 383 controls, especially in those under 6 years old (P = 0.01). This polymorphism has since been used as a functional variant to explore the role of elevated IL-6 levels in many common disease states, confirming the key causal role of IL-6 in human health and disease.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23543063      PMCID: PMC3613933          DOI: 10.1172/JCI67221

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  15 in total

1.  Interleukin-6 gene -174g>c and -572g>c promoter polymorphisms are strong predictors of plasma interleukin-6 levels after coronary artery bypass surgery.

Authors:  D J Brull; H E Montgomery; J Sanders; S Dhamrait; L Luong; A Rumley; G D Lowe; S E Humphries
Journal:  Arterioscler Thromb Vasc Biol       Date:  2001-09       Impact factor: 8.311

2.  Effects of genetic variation on chromatin structure and the transcriptional machinery: analysis of the IL6 gene locus.

Authors:  A J P Smith; D Zheng; J Palmen; D X Pang; P Woo; S E Humphries
Journal:  Genes Immun       Date:  2012-08-16       Impact factor: 2.676

3.  Randomized trial of tocilizumab in systemic juvenile idiopathic arthritis.

Authors:  Fabrizio De Benedetti; Hermine I Brunner; Nicolino Ruperto; Andrew Kenwright; Stephen Wright; Inmaculada Calvo; Ruben Cuttica; Angelo Ravelli; Rayfel Schneider; Patricia Woo; Carine Wouters; Ricardo Xavier; Lawrence Zemel; Eileen Baildam; Ruben Burgos-Vargas; Pavla Dolezalova; Stella M Garay; Rosa Merino; Rik Joos; Alexei Grom; Nico Wulffraat; Zbigniew Zuber; Francesco Zulian; Daniel Lovell; Alberto Martini
Journal:  N Engl J Med       Date:  2012-12-20       Impact factor: 91.245

4.  Association of serum interleukin-6 concentration with a functional IL6 -6331T>C polymorphism.

Authors:  Andrew J P Smith; Francesco D'Aiuto; Jutta Palmen; Jackie A Cooper; Jane Samuel; Simon Thompson; Julie Sanders; Nikos Donos; Luigi Nibali; David Brull; Pat Woo; Steve E Humphries
Journal:  Clin Chem       Date:  2008-03-20       Impact factor: 8.327

5.  Identification of a novel regulatory region in the interleukin-6 gene promoter.

Authors:  J M Samuel; D Kelberman; A J P Smith; S E Humphries; P Woo
Journal:  Cytokine       Date:  2008-04-11       Impact factor: 3.861

6.  The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis.

Authors:  D Fishman; G Faulds; R Jeffery; V Mohamed-Ali; J S Yudkin; S Humphries; P Woo
Journal:  J Clin Invest       Date:  1998-10-01       Impact factor: 14.808

7.  The -174G allele of the interleukin-6 gene confers susceptibility to systemic arthritis in children: a multicenter study using simplex and multiplex juvenile idiopathic arthritis families.

Authors:  Emma M Ogilvie; Mark S Fife; Susan D Thompson; Natalie Twine; Monica Tsoras; Marta Moroldo; Sheila A Fisher; Cathryn M Lewis; Anne-Marie Prieur; David N Glass; Patricia Woo
Journal:  Arthritis Rheum       Date:  2003-11

8.  The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysis.

Authors:  Daniel I Swerdlow; Michael V Holmes; Karoline B Kuchenbaecker; Jorgen E L Engmann; Tina Shah; Reecha Sofat; Yiran Guo; Christina Chung; Anne Peasey; Roman Pfister; Simon P Mooijaart; Helen A Ireland; Maarten Leusink; Claudia Langenberg; Ka Wah Li; Jutta Palmen; Philip Howard; Jackie A Cooper; Fotios Drenos; John Hardy; Michael A Nalls; Yun Rose Li; Gordon Lowe; Marlene Stewart; Suzette J Bielinski; Julian Peto; Nicholas J Timpson; John Gallacher; Malcolm Dunlop; Richard Houlston; Ian Tomlinson; Ioanna Tzoulaki; Jian'an Luan; Jolanda M A Boer; Nita G Forouhi; N Charlotte Onland-Moret; Yvonne T van der Schouw; Renate B Schnabel; Jaroslav A Hubacek; Ruzena Kubinova; Migle Baceviciene; Abdonas Tamosiunas; Andrzej Pajak; Roman Topor-Madry; Sofia Malyutina; Damiano Baldassarre; Bengt Sennblad; Elena Tremoli; Ulf de Faire; Luigi Ferrucci; Stefania Bandenelli; Toshiko Tanaka; James F Meschia; Andrew Singleton; Gerjan Navis; Irene Mateo Leach; Stephan J L Bakker; Ron T Gansevoort; Ian Ford; Stephen E Epstein; Mary Susan Burnett; Joe M Devaney; J Wouter Jukema; Rudi G J Westendorp; Gert Jan de Borst; Yolanda van der Graaf; Pim A de Jong; Anke-Hilse Mailand-van der Zee; Olaf H Klungel; Anthonius de Boer; Pieter A Doevendans; Jeffrey W Stephens; Charles B Eaton; Jennifer G Robinson; JoAnn E Manson; F Gerry Fowkes; Timonthy M Frayling; Jackie F Price; Peter H Whincup; Richard W Morris; Debbie A Lawlor; George Davey Smith; Yoav Ben-Shlomo; Susan Redline; Leslie A Lange; Meena Kumari; Nick J Wareham; W M Monique Verschuren; Emelia J Benjamin; John C Whittaker; Anders Hamsten; Frank Dudbridge; J A Chris Delaney; Andrew Wong; Diana Kuh; Rebecca Hardy; Berta Almoguera Castillo; John J Connolly; Pim van der Harst; Eric J Brunner; Michael G Marmot; Christina L Wassel; Steve E Humphries; Philippa J Talmud; Mika Kivimaki; Folkert W Asselbergs; Mikhail Voevoda; Martin Bobak; Hynek Pikhart; James G Wilson; Hakon Hakonarson; Alex P Reiner; Brendan J Keating; Naveed Sattar; Aroon D Hingorani; Juan Pablo Casas
Journal:  Lancet       Date:  2012-03-14       Impact factor: 79.321

9.  Open label phase II trial of single, ascending doses of MRA in Caucasian children with severe systemic juvenile idiopathic arthritis: proof of principle of the efficacy of IL-6 receptor blockade in this type of arthritis and demonstration of prolonged clinical improvement.

Authors:  Patricia Woo; Nicholas Wilkinson; Anne-Marie Prieur; Taunton Southwood; Valentina Leone; Polly Livermore; Helena Wythe; David Thomson; Tadamitsu Kishimoto
Journal:  Arthritis Res Ther       Date:  2005-09-15       Impact factor: 5.156

10.  Why most published research findings are false.

Authors:  John P A Ioannidis
Journal:  PLoS Med       Date:  2005-08-30       Impact factor: 11.613

View more
  9 in total

1.  The combined polymorphisms of interleukin-6-174GG genotype and interleukin-10 ATA haplotype are associated with a poor quality of life in patients with chronic hepatitis C.

Authors:  Diego Alves Vieira; Luciana Rodrigues da Cunha; Cliviany Borges da Silva; Maria Thereza Bastos Almeida; Adriana Dias Gomes; César Lúcio Lopes de Faria; Rosângela Teixeira; Fernando Silva Neves; Gifone Aguiar Rocha; Fabrício Freire de Melo; Dulciene Maria de Magalhães Queiroz; Luciana Diniz Silva
Journal:  Qual Life Res       Date:  2019-02-07       Impact factor: 4.147

2.  Lesson of the month 1: Septic arthritis with normal acute phase reactants and white cell count in a patient receiving tocilizumab.

Authors:  Richard Conway; Carl Orr; Geraldine M McCarthy
Journal:  Clin Med (Lond)       Date:  2017-06       Impact factor: 2.659

3.  Response to the dipeptidyl peptidase-4 inhibitors in Japanese patients with type 2 diabetes might be associated with a diplotype of two single nucleotide polymorphisms on the interleukin-6 promoter region under a certain level of physical activity.

Authors:  Mizue Matsui; Yoshihiko Takahashi; Noriko Takebe; Kazuma Takahashi; Kan Nagasawa; Hiroyuki Honma; Tomoyasu Oda; Mitsutaka Ono; Riyuki Nakagawa; Takayoshi Sasai; Hirobumi Togashi; Mari Hangai; Takashi Kajiwara; Haruhito Taneichi; Yasushi Ishigaki; Jo Satoh
Journal:  J Diabetes Investig       Date:  2014-07-25       Impact factor: 4.232

4.  Interleukin-6 Genetic Variation and Susceptibility to Gastric Cancer in an Iranian Population

Authors:  Marzieh Attar; Maryam Mansoori; Majid Shahbazi
Journal:  Asian Pac J Cancer Prev       Date:  2017-11-26

Review 5.  COVID-19 and Alzheimer's Disease.

Authors:  Marcello Ciaccio; Bruna Lo Sasso; Concetta Scazzone; Caterina Maria Gambino; Anna Maria Ciaccio; Giulia Bivona; Tommaso Piccoli; Rosaria Vincenza Giglio; Luisa Agnello
Journal:  Brain Sci       Date:  2021-02-27

6.  Manipulation of Interleukin-6 (IL-6) and Transforming Growth Factor Beta-1(TGFβ-1) towards viral induced liver cancer pathogenesis.

Authors:  Yasmin Badshah; Maria Shabbir; Khushbukhat Khan; Maha Fatima; Iqra Majoka; Laiba Aslam; Huda Munawar
Journal:  PLoS One       Date:  2022-10-10       Impact factor: 3.752

7.  Immune System and Neuroinflammation in Idiopathic Parkinson's Disease: Association Analysis of Genetic Variants and miRNAs Interactions.

Authors:  Claudia Strafella; Valerio Caputo; Andrea Termine; Francesca Assogna; Clelia Pellicano; Francesco E Pontieri; Lucia Macchiusi; Giulietta Minozzi; Stefano Gambardella; Diego Centonze; Paola Bossù; Gianfranco Spalletta; Carlo Caltagirone; Emiliano Giardina; Raffaella Cascella
Journal:  Front Genet       Date:  2021-06-03       Impact factor: 4.599

8.  Genetic modulation of the interleukin 6 (IL-6) system in patients with advanced gastric cancer: a background for an alternative target therapy.

Authors:  Annamaria Ruzzo; Vincenzo Catalano; Emanuele Canestrari; Elisa Giacomini; Daniele Santini; Giuseppe Tonini; Bruno Vincenzi; Giammaria Fiorentini; Mauro Magnani; Francesco Graziano
Journal:  BMC Cancer       Date:  2014-05-22       Impact factor: 4.430

9.  Loss of Interleukin-6 Influences Transcriptional Immune Signatures and Alters Bacterial Colonization in the Skin.

Authors:  Lerin R Luckett-Chastain; Catherine J King; William M McShan; Jenny R Gipson; Allison F Gillaspy; Randle M Gallucci
Journal:  Front Microbiol       Date:  2021-07-06       Impact factor: 5.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.